Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Vivendi SE
  6. News
  7. Summary
    VIV   FR0000127771

VIVENDI SE

(VIV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Havas Health & You Appoints Tara Stewart As Managing Director, Havas Health CX

12/01/2021 | 10:15am EST

NEW YORK, Dec. 1, 2021 /CNW/ -- To help health companies navigate the immense shifts in patient and provider behavior around medical technologies and therapies brought about by COVID-19, Havas Health & You today announced that Tara Stewart, longtime pharmaceutical executive, will join HHCX on December 8th as its Managing Director. The move will leverage Tara's extensive omnichannel expertise to help HHCX strategically meet expanding demand from enterprise clients, and it complements the appointment of HHCX's notable Chief Creative and Design Officer Jane Motz Hayes.

Tara brings a wealth of agency and client-side experience across different verticals of the health communications industry to this role. Most recently, she served as Vice President, Engagement Planning and Content at Bristol Myers Squibb, where she was responsible for the company's Omnichannel transformation and oversaw a large, diverse global team. She has also held key roles at Pfizer and Digitas Health.

"I couldn't be more excited to be joining the Havas Health CX team. With an amazing team and the solid foundation of the whole Havas network, we will be well poised to support HHCX's growth and demand. I was drawn to the organization because of its deep focus on and passion about CX, data driven experiences and the desire to exceed expectations," said Tara Stewart, Managing Director, HHCX. "Together, we will continue to make a difference in health outcomes and deliver personalized experiences, taking clients on the journey and helping them realize the art and possibility in CX and in Life Sciences."

Tara will report to Pat Thistlethwaite, Chief Experience Officer at Havas Health & You, who spearheaded HHCX's growth across North America and Europe – a network that spans the London, Paris, New York, and Toronto offices. In that time, HHCX has added both standalone clients like New York Presbyterian Hospital and Florida Blue Cross Blue Shield, and has lent support for Network clients like Novartis, Pfizer and Sanofi. Transferring leadership of HHCX to Tara will help facilitate Pat's shift in focus to building CX capability in Havas Network agencies across the world. He will retain his current title and also be taking on a leadership role focused on elevating and scaling HH&Y's new advanced data offerings globally.

"In CX at Havas, our goal is to create things that improve health. Our clients agree - they are demanding data-led customer experience, omnichannel and product design at unprecedented levels," said Pat Thistlethwaite, Chief Experience Officer at Havas Health & You. "I'm excited to work with the network to scale these offerings, and to differentiate them through the development of new, advanced capability." 

CX offerings within the Havas network are guided by the principle that the best CX is data-led and customer centered.  To help advance this mission, HH&Y is investing significantly in People, Processes and Technology supporting the advanced use of data to drive personalized, impactful experiences that improve health outcomes.

#####

About Havas Health & You

Havas Health & You unites Havas Life, Health4Brands (H4B), Lynx, Red Havas and Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group. The network's approach is centered around Human Purpose and has the talent, tenacity, and technology that health companies, brands and people need to thrive in today's world. For more information, go to www.HavasHealthandYou.com.

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/havas-health--you-appoints-tara-stewart-as-managing-director-havas-health-cx-301434728.html

SOURCE Havas Health & You

© Canada Newswire, source Canada Newswire English

All news about VIVENDI SE
02:42pTelecom Italia GM outlines plans as doubts on KKR's bid mount
RE
09:23aTelecom Italia To Review Potential New CEO's Plan Amid KKR's Takeover Offer
MT
09:10aFactbox-Biggest deals in the consolidating videogame market
RE
08:23aTelecom Italia GM to outline plans as doubts on KKR's bid mount
RE
03:37aVivendi Acquires Over 8% Stake In Progressif Media From ZeWatchers
MT
03:09aVivendi invests in digital communication group Progressif Media
RE
01/14Game Developer -Colorful Medieval-Inspired Strategic Game Idle Siege Available Now on t..
AQ
01/13Italy to impose cap in tender for broadband rollout, sources say
RE
01/12Italy says it wants control of key Telecom Italia assets in any KKR bid
RE
01/12Italy says it wants control of key Telecom Italia assets in any KKR bid
RE
More news
Analyst Recommendations on VIVENDI SE
More recommendations
Financials
Sales 2021 9 455 M 10 709 M 10 709 M
Net income 2021 429 M 486 M 486 M
Net cash 2021 876 M 992 M 992 M
P/E ratio 2021 26,3x
Yield 2021 2,90%
Capitalization 12 424 M 14 078 M 14 072 M
EV / Sales 2021 1,22x
EV / Sales 2022 1,17x
Nbr of Employees 42 800
Free-Float -
Chart VIVENDI SE
Duration : Period :
Vivendi SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIVENDI SE
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 11,85 €
Average target price 13,76 €
Spread / Average Target 16,1%
EPS Revisions
Managers and Directors
Arnaud Roy de Puyfontaine Chairman-Management Board & CEO
HervÚ Philippe Chief Financial Officer
Yannick BollorÚ Chairman-Supervisory Board
StÚphane Roussel Executive VP-Development & Organization
Caroline Le Masne de Chermont Senior VP-Legal Affairs, CSR & Compliance
Sector and Competitors
1st jan.Capi. (M$)
VIVENDI SE-0.38%14 370
WARNER MUSIC GROUP CORP.-6.74%20 720
BOLLORÉ SE-1.71%16 256
ENDEAVOR GROUP HOLDINGS, INC.-12.75%8 491
BEIJING ENLIGHT MEDIA CO., LTD.-10.66%5 388
SHANGHAI ORIENTAL PEARL GROUP CO., LTD.6.35%5 062